Adjuvant chemotherapy in postmenopausal women: Results of sequential noncross‐resistant regimens
- 1 October 1985
- journal article
- clinical trial
- Published by Wiley in World Journal of Surgery
- Vol. 9 (5), 728-737
- https://doi.org/10.1007/bf01655188
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Association of disease-free survival and percent of ideal dose in adjuvant breast chemotherapyCancer, 1990
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerBreast Cancer Research and Treatment, 1985
- REVIEW OF MORTALITY RESULTS IN RANDOMISED TRIALS IN EARLY BREAST CANCERThe Lancet, 1984
- CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL FOR BREAST CANCERThe Lancet, 1984
- Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCERThe Lancet, 1983
- Dose-Response Effect of Adjuvant Chemotherapy in Breast CancerNew England Journal of Medicine, 1981
- Response and survival in advanced breast cancer after two non-cross-resistant combinations.BMJ, 1976
- Combination Chemotherapy as an Adjuvant Treatment in Operable Breast CancerNew England Journal of Medicine, 1976
- L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast CancerNew England Journal of Medicine, 1975